Maximal rise in IgE antibody following ragweed pollination season
- PMID: 45925
- DOI: 10.1016/s0091-6749(75)80003-0
Maximal rise in IgE antibody following ragweed pollination season
Abstract
Patients allergic to ragweed pollen who did not receive immunotherapy had an increase in ragweed-specific IgE antibodies associated with seasonal exposure. Of 17 such patients, 15 reached peak levels between mid-September and mid-October. Two had peak values after mid-October; the levels were only slightly higher than earlier values. Our study shows that serum obtained in mid-October reflects approximately the maximal IgE antibody level attained 0y ragweed-sensitive patients in our area and that this value can be used as a baseline in monitoring the subsequent decline in antibodies. In addition, our data support an earlier observation that the magnitude of seasonal rise in IgE antibody is related to the preseasonal value. The significantly positive correlation of the results of carefully performed skin tests (end point titration) with radioallergosorbent test (RAST) values suggests the possibility that the RAST can be employed as a reliable diagnostic aid, perhaps even replacing the skin test.
Similar articles
-
Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.J Clin Invest. 1973 May;52(5):1268-75. doi: 10.1172/JCI107294. J Clin Invest. 1973. PMID: 4735589 Free PMC article.
-
Relationship of immunotherapy, seasonal pollen exposure and clinical response to serum concentrations of total IgE and ragweed-specific IgE.Int Arch Allergy Appl Immunol. 1975;48(6):721-30. doi: 10.1159/000231360. Int Arch Allergy Appl Immunol. 1975. PMID: 1170137
-
Immunologic and cellular changes accompanying the therapy of pollen allergy.J Clin Invest. 1971 Feb;50(2):360-9. doi: 10.1172/JCI106503. J Clin Invest. 1971. PMID: 4099843 Free PMC article. Clinical Trial.
-
The effect of cromolyn sodium powder as a treatment for ragweed pollinosis.J Allergy Clin Immunol. 1975 Dec;56(6):481-90. doi: 10.1016/0091-6749(75)90066-4. J Allergy Clin Immunol. 1975. PMID: 812895 Clinical Trial.
-
Clinical evaluation and therapy of allergic rhinitis in adults.Clin Rev Allergy. 1984 Aug;2(3):189-96. doi: 10.1007/BF02991099. Clin Rev Allergy. 1984. PMID: 6207903 Review. No abstract available.
Cited by
-
Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response.EBioMedicine. 2019 Dec;50:421-432. doi: 10.1016/j.ebiom.2019.11.006. Epub 2019 Nov 28. EBioMedicine. 2019. PMID: 31786130 Free PMC article.
-
Food allergies: the basics.Gastroenterology. 2015 May;148(6):1120-31.e4. doi: 10.1053/j.gastro.2015.02.006. Epub 2015 Feb 11. Gastroenterology. 2015. PMID: 25680669 Free PMC article. Review.
-
A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.J Immunol. 2017 Feb 15;198(4):1685-1695. doi: 10.4049/jimmunol.1501741. Epub 2017 Jan 16. J Immunol. 2017. PMID: 28093528 Free PMC article.
-
Suppression by relevant allergen of the spontaneous in vitro production of rye group I specific IgE antibodies by human peripheral blood lymphocytes.Clin Exp Immunol. 1987 Feb;67(2):391-7. Clin Exp Immunol. 1987. PMID: 3608228 Free PMC article.
-
Vaccination with genetically engineered allergens prevents progression of allergic disease.Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14677-82. doi: 10.1073/pnas.0404735101. Epub 2004 Aug 13. Proc Natl Acad Sci U S A. 2004. PMID: 15310844 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources